Management of refractory congestive heart failure (Q36303919)

13 August 2017

1 reference

title

Management of refractory congestive heart failure (English)

1 reference

Cardiology and cardiovascular medicine

13 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

17 October 2022

congestive heart failure

1 reference

R. J. Cody

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1626487

17 October 2022

language of work or name

English

0 references

publication date

1 June 1992

1 reference

13 August 2017

4 June 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1626487

full work available at URL

17 October 2022

https://api.elsevier.com/content/article/PII:0002914992912623?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

https://api.elsevier.com/content/article/PII:0002914992912623?httpAccept=text/plain

17 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

American Journal of Cardiology

17 October 2022

published in

1 reference

13 August 2017

volume

69

1 reference

13 August 2017

issue

18

1 reference

13 August 2017

page(s)

141G-147G; disc. 147G-149G

1 reference

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

13 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

17 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Epidemiology of congestive heart failure

17 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

17 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

17 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

17 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Severe "silent" mitral regurgitation. A potentially reversible cause of refractory heart failure

17 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy

17 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Atherosclerosis in diabetes: the role of hyperinsulinemia

17 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Regulation of glomerular filtration rate in chronic congestive heart failure patients

17 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Heart failure in outpatients: a randomized trial of digoxin versus placebo

17 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

17 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure

17 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Resistance to loop diuretics. Why it happens and what to do about it.

17 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Loop Diuretics for Chronic Renal Insufficiency: A Continuous Infusion Is More Efficacious Than Bolus Therapy

17 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion

17 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure

17 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Hemofiltration as short-term treatment for refractory congestive heart failure

17 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases

17 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Flosequinan: a vasodilator with positive inotropic activity.

17 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Pharmacology of angiotensin-converting enzyme inhibitors as a guide to their use in congestive heart failure

17 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Sodium and water balance in chronic congestive heart failure

17 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Combined vasodilator therapy for chronic congestive heart failure

17 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure

17 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy

17 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Left ventricular shape as a determinant of functional mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy

17 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Functional left ventricular aneurysm formation after acute anterior transmural myocardial infarction. Incidence, natural history, and prognostic implications

17 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy

17 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Physiologic mechanisms governing hemodynamic responses to positive inotropic therapy in patients with dilated cardiomyopathy.

17 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure

17 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

17 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.

17 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure

17 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91262-3

17 October 2022

Identifiers

1 reference

13 August 2017

1 reference